<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">PAR</journal-id><journal-title-group><journal-title>Proceedings of Anticancer Research</journal-title></journal-title-group><issn>2208-3545</issn><eissn>2208-3553</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/par.v9i4.11567</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Research Progress in Emergency Treatment for Patients with Cerebral Hemorrhage</title><url>https://artdesignp.com/journal/PAR/9/4/10.26689/par.v9i4.11567</url><author>ZhangCong,WangEryi</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>9</volume><issue>4</issue><history><date date-type="pub"><published-time>2025-08-07</published-time></date></history><abstract>As a severe neurological disease, cerebral hemorrhage is dangerous and progresses rapidly, with high disability and fatality rates. Its occurrence seriously harms patients’ lives and health, and also causes a heavy social burden. Timely diagnosis and treatment of cerebral hemorrhage are essential for improving patients’ prognosis. This article reviews the research progress in emergency treatment for patients with cerebral hemorrhage, providing a basis for diagnosis and treatment.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Arndt P, Chahem C, Luchtmann M, et al., 2024, Risk Factors for Intracerebral Hemorrhage in Small-Vessel Disease and Non-Small-Vessel Disease Etiologies—An Observational Proof-of-Concept Study. Front Neurol, 15: 1322442.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Xu L, Wang Z, Wu W, et al., 2024, Global, Regional, and National Burden of Intracerebral Hemorrhage and Its Attributable Risk Factors from 1990 to 2021: Results from the 2021 Global Burden of Disease Study. BMC Public Health, 24(1): 2426.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Larsson S, Chen J, Gill D, et al., 2024, Risk Factors for Intracerebral Hemorrhage: Genome-Wide Association Study and Mendelian Randomization Analyses. Stroke, 55(6): 1582–1591.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Tan L, Wang C, 2024, Correlation Analysis between Serum Galectin-9 and PD-L1 Protein Levels and Severity and Prognosis of Hypertensive Cerebral Hemorrhage Patients. Anhui Medical and Pharmaceutical Journal, 28(10): 2069–2072.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Liu C, Xie K, Xu F, et al., 2023, The Effect of Early Intensive Blood Pressure Lowering on the Prognosis of Patients with Hypertensive Cerebral Hemorrhage. Chinese Journal of Clinical Research, 36(3): 339–342.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Wang Y, Qin Y, Guo C, et al., 2024, A Prospective Study on the Relationship between Early Blood Pressure Management and Prognosis of Patients with Acute Hypertensive Cerebral Hemorrhage. Chinese Journal of Emergency Resuscitation and Disaster Medicine, 19(2): 183–186.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Baharoglu M, Cordonnier C, Salman R, et al., 2016, Platelet Transfusion versus Standard Care after Acute Stroke Due to Spontaneous Cerebral Haemorrhage Associated with Antiplatelet Therapy (PATCH): A Randomised, Open-Label, Phase 3 Trial. Lancet, 387(10038): 2605–2613.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Li H, 2023, Tranexamic Acid for the Treatment of Non-Vitamin K Antagonist Oral Anticoagulant-Associated Intracerebral Hemorrhage. International Journal of Cerebrovascular Diseases, 31(9): 657.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Babi M, James M, 2017, Peri-Hemorrhagic Edema and Secondary Hematoma Expansion after Intracerebral Hemorrhage: From Benchwork to Practical Aspects. Front Neurol, 8: 4.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Zhou X, Liu C, Zhang H, 2024, Evaluation of the Effect of Hemostatic Agents in Patients with Hypertensive Cerebral Hemorrhage Based on CYP2C19 Gene Methylation Level and Thrombelastography Parameters. Hebei Medical Journal, 46(7): 997–1001.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
